Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > How quick these pumpers forget…
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(49)
•••
Comment by TrippinAgain01on Jan 21, 2023 9:00pm
184 Views
Post# 35237867

RE:RE:RE:How quick these pumpers forget…

RE:RE:RE:How quick these pumpers forget…

2020, 2021, 2022....? With exception to the 95% share price drop, the fake launch, and the analyst running for his life, NOTHING HAPPENED! You say I got the 2019 numbers wrong and you were finally correct!

I always quote 160K but it was only actually 138K total revenue. PATHETIC!

Any person who tell their entire shareholder base they are expecting 30 million in revenue confidently like a dozen times and then can only produce 138K is a bonified moron or criminal. Take your pick.


YOU MUST HAVE NO BRAIN AND BE CLINICALLY INSANE TO GIVE MORE OF YOUR MONEY TO THIS SAME PERSON.

User image

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities